Neoadjuvant Combo Reduces Volume of High-Risk Prostate Tumors
Abiraterone plus prednisone combined with leuprolide decreases tumor size compared with leuprolide alone in men with high-risk prostate cancer.
All articles by John Schieszer
PCa Recurrence Predictors in Whole Gland Cryotherapy Identified
Older age and high-risk disease are among the factors independently associated with biochemical recurrence of prostate cancer following whole gland cryotherapy.
Non-Standard Therapies Used in 20% of Localized High-Risk PCa Cases
Using EBRT alone or ADT alone for high-risk localized prostate cancer is associated with worse survival outcomes.
Prostate Cancer ADT Found to Increase Depression Risk
Men who receive androgen deprivation therapy after radical prostatectomy have a nearly 2-fold increased risk of depression compared with those who receive no post-surgical treatment.
Adjuvant Docetaxel Possibly Beneficial in High-Risk Prostate Cancer
In a study, adding docetaxel to androgen deprivation and radiation therapy for selected men with high-risk localized prostate cancer improved overall and metastasis-free survival.
Bladder Cancer Surgery Delay Increases Death Risk
Patients who undergo radical cystectomy for MIBC more than 12 weeks from diagnosis are at increased risk of death, regardless of whether they receive neoadjuvant chemotherapy.
Drug Treats Hyperphosphatemia Without Binding Phosphate
In a phase 3 trial, tenapanor, which reduces paracellular phosphate transport in the intestine, lowered elevated serum phosphorus in patients on hemodialysis.
Hyperkalemia Events Common With RAAS Inhibitor Use in CKD
Almost half of incident hyperkalemia events are followed by changes in RAAS inhibitor therapy.
BPH Prostatic Artery Embolization Facilitated With MR Angiography
Improved visualization of prostatic arteries shortens procedure time and decreases radiation exposure, new findings suggest.
Obstructive Sleep Apnea Treatment May Slow CKD Progression
In a study, CKD patients with OSA treated with nasal continuous positive airway pressure (CPAP) had significantly higher eGFR after 12 months of treatment than those not receiving CPAP.
Next post in Chronic Kidney Disease (CKD)
